Literature DB >> 10353160

Inhibition of keratinocyte growth by different Nepalese zanthoxylum species.

S Kumar1, K Müller.   

Abstract

A total of 11 methanol extracts obtained from four different Nepalese Zanthoxylum species were screened for their antiproliferative activity against the growth of human keratinocytes (HaCaT cells). The extract obtained from Z. armatum barks was highly active with an IC50 value of 11 micrograms/mL. Also, the extracts obtained from Z. oxyphyllum barks and roots with IC50 values of 53 and 57 micrograms/mL, respectively, showed potent activity. Their antiproliferative activity was not due to cytotoxic effects on cell membranes, as documented by the activity of lactate dehydrogenase released from the cytoplasm of keratinocytes, which did not exceed that of the control value. Rather, they also protected against radical-induced damage to model membranes stimulated with 2,2'-azo-bis(2-amidinopropane) dihydrochloride.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353160     DOI: 10.1002/(SICI)1099-1573(199905)13:3<214::AID-PTR431>3.0.CO;2-2

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  4 in total

1.  Pharmacognostic study and development of quality control parameters for fruit, bark and leaf of Zanthoxylum armatum (Rutaceae).

Authors:  Fiaz Alam; Qazi Najam Us Saqib
Journal:  Anc Sci Life       Date:  2015 Jan-Mar

2.  High gene flow and genetic diversity in three economically important Zanthoxylum Spp. of Upper Brahmaputra Valley Zone of NE India using molecular markers.

Authors:  K Medhi; D K Sarmah; M Deka; B S Bhau
Journal:  Meta Gene       Date:  2014-10-08

3.  Evaluation of Zanthoxylum armatum Roxb for in vitro biological activities.

Authors:  Fiaz Alam; Qazi Najam Us Saqib
Journal:  J Tradit Complement Med       Date:  2017-02-14

4.  Cytotoxic activity of extracts and crude saponins from Zanthoxylum armatum DC. against human breast (MCF-7, MDA-MB-468) and colorectal (Caco-2) cancer cell lines.

Authors:  Fiaz Alam; Qazi Najum Us Saqib; Abdul Waheed
Journal:  BMC Complement Altern Med       Date:  2017-07-17       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.